NEWS & RESOURCES

Estrigenix in the news

CSO Karyn Frick discusses “Why women are more likely to develop Alzheimer’s Disease” on Chicago radio WLS 890AM (the Big 89)

MILWAUKEE (October 25, 2023) – Estrigenix Therapeutics, Inc., a Wisconsin-based, privately held pharmaceutical company is leading the way in estrogen biology. Karyn Frick, Ph.D, chief scientific officer of Estrigenix spoke with Rob Johnson and Jane Clauss of Chicago radio “The Big 89” regarding Alzheimer’s Disease and the increased risk for…

READ MORE

Estrigenix Therapeutics to Attend The Menopause Society Meeting

MILWAUKEE (Sept. 22, 2023) – Estrigenix Therapeutics, Inc., is announcing Patricia Scheller, Executive Chairwoman, and Daniel Sem, VP for Business Development will attend the The Menopause Society, (formerly known at the North American Menopause Society) Annual Meeting in Philadelphia September 27 – 30, 2023. The Menopause Society is the premier…

READ MORE

Estrigenix welcomes new employees

Estrigenix Therapeutics welcomed two new employees this summer, Ms. Elaina Milkie and Dr. Dulanjali Thennakoon. Ms. Elaina Milkie graduated with B.S. from the University of Wisconsin-Milwaukee (UWM) in May 2023, double majoring in Psychology and Biological Sciences. Elaina worked part time with Estrigenix in spring 2023 while completing her degree…

READ MORE
Load More